Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.25
+7.48 (3.50%)
AAPL  258.90
+5.40 (2.13%)
AMD  231.82
+10.29 (4.64%)
BAC  51.88
+1.60 (3.18%)
GOOG  314.74
+10.81 (3.56%)
META  612.42
+37.37 (6.50%)
MSFT  374.33
+2.04 (0.55%)
NVDA  182.08
+3.98 (2.23%)
ORCL  143.66
+0.49 (0.34%)
TSLA  343.25
-3.40 (-0.98%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.